Characterization of the vaccinia MVA hemagglutinin gene locus and its evaluation as an insertion site for foreign genes

Gene

Volumn 177, Issue 1-2, 1996, Pages 43-46

  Antoine, Gerhard ^a   Scheiflinger, Friedrich ^a   Holzer, Georg ^a   Langmann, Thomas ^a,b   Falkner, Falko G ^a   Dorner, Friedrich ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Bender MedSystems   (Austria)

Author keywords

Deletion III; ha gene promoter; Recombinant Modified Vaccinia Ankara

Indexed keywords

RECOMBINANT DNA; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ARTICLE; GENE FUNCTION; GENE INSERTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY; VACCINIA VIRUS; VIRUS GENE; VIRUS RECOMBINANT;

ANKARA; VACCINIA; VACCINIA VIRUS;

EID: 0030600451     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1119(96)00267-3     Document Type: Article

References (23)

1. Brown, C.K., Bloom, D.C. and Moyer, R.W. (1991a) The nature of naturally occurring mutations in the hemagglutinin gene of vaccinia virus and the sequence of immediately adjacent genes. Virus Genes 5, 235-242.
2. Brown, C.K., Turner, P.C. and Moyer, R.W. ( 1991b) Molecular characterization of the vaccinia virus hemagglutinin gene. J. Virol. 65, 3598-3606.
3. Buller, R.M.L. and Palumbo, GJ. (1992) Safety and attenuation of vaccinia virus. In: Binns, M.M. and Smith. G.L. (Eds.), Recombinant Poxviruses. CRC Press, Boca Raton, FL, pp. 235-267.
4. Cavallaro, K.F. and Esposito, J.J. (1992) Sequences of the raccoon poxvirus hemagglutinin protein. Virology 190, 434-439.
5. Chakrabarti, S., Brechling, K. and Moss, B. (1985) Vaccinia virus expression vector: coexpression of ß-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403-3409.
6. Falkner, F.G. and Moss, B. (1988) Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62, 1849-1854.
7. Flexner, C., Hügin, A. and Moss, B. (1987) Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature 330, 259-261.
8. Goebel, S.J., Johnson, G.P., Perkus, M.E., Davis, S.W., Winslow, J.P. and Paoletti, E. (1990) The complete DNA sequence of vaccinia virus. Virology 179, 247-266.
9. Jin, D., Li, Z., Jin, Q., Hao, Y., Hou, Y. (1989) Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily. J. Exp. Med. 170, 571-576.
10. Kempe, C.H., Fulginiti, V., Minimitani, M. and Shinfield, H. (1968) Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CV1-78). Pediatrics 42, 980-985.
11. Langmann, T. (1991) Untersuchungen zur Expression von Blutfaktoren unter Anwendung des Vaccinia Virus Systems. Diploma Thesis, Univ. Wien.
12. Mackett, M., Smith, G.L. and Moss, B. (1985) The construction and characterization of vaccinia virus recombinants expressing foreign genes. In: Glover, D.M. (Ed.), DNA cloning: A practical approach. IRL Press, Oxford, pp. 191-211.
13. Mahnel, H. and Mayr, A. (1994) Erfahrungen bei der Schutzimpfung gegen Orthopocken von Mensch und Tier mit dem Impfstamm MVA. Berl. Münch. Tierärztl. Wschr. 107, 253-256.
14. Mayr, A., Stickl, H., Müller, H.K., Danner, K. and Singer, H. (1978) The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism. Zbl. Bakt. Hyg., I. Abt. Orig. B 167, 375-390.
15. Meyer, H., Sutter, G. and Mayr, A. (1991) Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72, 1031-1038.
16. Moss, B. (1991) Vaccinia virus: a tool for research and vaccine development. Science 252, 1662-1667.
17. Scheiflinger, F.S., Falkner, F.G. and Dorner, F. (1996) Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain. Arch. Virol. 141, 663-669.
18. Shida, H. (1986) Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150, 451-462.
19. Smith, G.L., Chan, Y.S. and Howard, S.T. (1991) Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 72, 1349-1376.
20. Sugimoto, M. and Yamanouchi, K. (1994) Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines. Vaccine 12, 675-681.
21. Sutter, G. and Moss, B. (1992) Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89, 10847-10851.
22. Sutter, G., Wyatt, L.S., Foley, P.L., Bennink, J.R. and Moss, B. (1994) A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12, 1032-1040.
23. Tartaglia, J., Perkus, M.E., Taylor, J., Norton, E.K., Audonnet, J.-C., Cox, W.I., Davis, S.W., van der Hoeven, J., Meignier, B., Riviere, M., Languet, B. and Paoletti, E. (1992) NYVAC: a highly attenuated strain of vaccinia virus. Virology 188, 217-232.